Christopher R. Fenimore, VP Controller at REGENERON PHARMACEUTICALS INC (REGN), sold 3,798 shares at $356.27 ($1.4M) on 2018-12-20, disclosed to the SEC on 2018-12-20.
Open-market sale of $1.4M REGN by VP Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $364.42 | 1,602 | $584K | 42.6% |
| 2 | $355.14 | 100 | $36K | 2.6% |
| 3 | $356.27 | 348 | $124K | 9.0% |
| 4 | $356.27 | 348 | $124K | 9.0% |
| 5 | $357.50 | 200 | $72K | 5.2% |
| 6 | $358.27 | 200 |
| $72K |
| 5.2% |
| 7 | $359.38 | 200 | $72K | 5.2% |
| 8 | $360.40 | 500 | $180K | 13.1% |
| 9 | $361.65 | 100 | $36K | 2.6% |
| 10 | $362.45 | 200 | $72K | 5.3% |
| Total | $361.02 avg | 3,798 | $1.4M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |